M-BACOD regimen
WikiDoc Resources for M-BACOD regimen |
Articles |
---|
Most recent articles on M-BACOD regimen Most cited articles on M-BACOD regimen |
Media |
Powerpoint slides on M-BACOD regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on M-BACOD regimen at Clinical Trials.gov Trial results on M-BACOD regimen Clinical Trials on M-BACOD regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on M-BACOD regimen NICE Guidance on M-BACOD regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on M-BACOD regimen Discussion groups on M-BACOD regimen Patient Handouts on M-BACOD regimen Directions to Hospitals Treating M-BACOD regimen Risk calculators and risk factors for M-BACOD regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for M-BACOD regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: m-BACOD Regimen; Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen
Overview
M-BACOD regimen refers to a regimen consisting of methotrexate, bleomycin, doxorubicin (adriamycin), cyclophosphamide, vincristine and dexamethasone used to treat aggressive forms of non-Hodgkin's lymphoma.[1][2]
Regimen
MMethotrexate BBleomycin ADoxorubicin (Adriamycin)
CCyclophosphamide
OVincristine (Oncovin)
DDexamethasone
Indications
References
- ↑ "NCI Thesaurus".
- ↑ 2.0 2.1 Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS; et al. (1990). "The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen". J Clin Oncol. 8 (1): 84–93. PMID 1688615.
- ↑ "NCI Thesaurus".